FOOTPATH: A Randomized, Open-Label Phase-2 Study of Liposomal Irinotecan + 5-FU and Folinic Acid (NAPOLI) Versus Sequential NAPOLI and Mfolfox6 Versus Gemcitabine/nab-Paclitaxel in Treatment-Naïve Metastatic Pancreatic Cancer (Mpdac).
JOURNAL OF CLINICAL ONCOLOGY(2023)
关键词
Metastatic Pancreatic Cancer
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要